Our team actively participated in the congress, diving deep into arterial interventions. Over the past few days, Helena Ossmer Thedius, Chief Marketing and Innovation Officer at Magle Group, and Franziska Sahm, Dr. Medical Affairs Manager at Magle PharmaCept, have attended highly informative meetings at CIRSE 2024. The congress provided an opportunity for participants to gain […]
Magle PharmaCept, a subsidiary of Magle Group, is pleased to announce the extension of its distribution agreement with its key distributor in the wound care field. The expanded agreement now includes strategic European territories, enhancing our reach and reinforcing our commitment to providing innovative wound care solutions across the region. AXXO® Woundgel, the brand owned […]
At Magle Group, our unwavering commitment to excellence drives us forward. Recently Magle Chemoswed announced the partnership with Dara Pharmaceutical Equipment, resulting in the acquisition of a state-of-the-art automated syringe filling and closing line. Our aspiration is to provide high quality healthcare innovations while constantly expanding our capabilities. With this remarkable addition, we’re taking a […]
At Magle PharmaCept, we are excited to announce our participation in the European Conference on Embolotherapy ET2024 Congress, in Vienna, where we gain Insights and focus on embolization in various areas. Attending sessions and connecting with partners and healthcare professionals broaden our understanding of user needs and create value for patients. collaboration between different specialties […]
Magle Group, through its subsidiary Magle PharmaCept, is excited to announce the appointment of a new distributor for SmartPAN® in Singapore. This strategic partnership represents a pivotal step in our efforts to introduce SmartPAN® to the Asian market, underlining our commitment to improving pancreatic surgery outcomes globally. Regulatory approval for SmartPAN® in Singapore is currently […]
Our team was participating in the 43rd Annual Meeting of the German Pancreas Club from February 15th – 17th, 2024. Our team members have been actively engaged in the Deutscher Pankreasclub lectures, poster sessions, and workshops, focusing on basic science breakthroughs in pancreatic cancer, along with the latest clinical and basic science innovations. The program […]
New study from Frankfurt University Hospital, Prof. Vogl has been published “Degradable Starch Microspheres Transarterial Chemoembolization with or without Lipiodol for Liver Metastases from Pancreatic Cancer: A Prospective Randomized Trial”. Check out the link below for the full article. Read More
Magle Group (Nasdaq Stockholm First North Growth Market: MAGLE) today 2023-09-08 16:05, announces the establishment of a collaboration and exclusive worldwide distribution agreement with the global medical device company Sirtex Medial pertaining to its chemoembolization product EmboCept® S DSM 50 µm. The main purpose is to accelerate internationalization, drive growth in new geographic areas, and […]
Magle Group (Nasdaq Stockholm First North Growth Market: MAGLE) today 2023-06-28 11:05 announces that the company has established a collaboration with Charité – Universitätsmedizin Berlin to evaluate the combination of its vascular embolic agent EmboCept® S DSM 50 µm and immunotherapy. As a first step of the collaboration, the parties are planning a study to […]
Magle Group (Nasdaq Stockholm First North Growth Market: MAGLE) today 2023-04-27 08:30 announces the presentation of data from the company’s first post-market clinical follow-up study of SmartPAN® – an innovative first-in-class medical device developed to improve the outcome of pancreatic surgery. The results were presented at the 140th German Surgery Congress, April 26-28th in Munich. […]
